Phase I study of the BLP25 (MUC1 peptide) liposomal vaccine for active specific immunotherapy in stage IIIB/IV non-small-cell lung cancer (Q79345729)
Jump to navigation
Jump to search
scientific article published on 01 August 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of the BLP25 (MUC1 peptide) liposomal vaccine for active specific immunotherapy in stage IIIB/IV non-small-cell lung cancer |
scientific article published on 01 August 2001 |
Statements
Phase I study of the BLP25 (MUC1 peptide) liposomal vaccine for active specific immunotherapy in stage IIIB/IV non-small-cell lung cancer (English)
M Palmer
J Parker
S Modi
C Butts
M Smylie
A Meikle
M Kehoe
G MacLean
M Longenecker
1 August 2001
49-57; discussion 58